invIOs presents positive patient data from ongoing Phase 1b
Poster presentation shows treatment with APN401, an autologous cell therapy product targeting the master immune checkpoint Cbl-b, resulted in stabilization...
Source: globenewswire.com
Stay updated with breaking news from Ios Cbl B. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poster presentation shows treatment with APN401, an autologous cell therapy product targeting the master immune checkpoint Cbl-b, resulted in stabilization...